CHAMPIONS BIOTECHNOLOGY, INC.

CHAMPIONS BIOTECHNOLOGY, INC. insiders are currently net buyers of CSBR stock, showing neutral sentiment over the past 90 days. Executives have purchased $13.6M while selling $9.1M, resulting in a positive net flow of $4.5M. This buying activity represents 60% of total transaction volume.

CHAMPIONS BIOTECHNOLOGY, INC. has 17 active insiders who have filed SEC Form 4 transactions in the past 90 days. 14 Gp, Ltd Nea (Executive) leads with 2 transactions totaling $9.9M. Ronnie Morris (Executive) follows with 34 transactions worth $5.7M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. CHAMPIONS BIOTECHNOLOGY, INC.'s current score of 60/100 indicates neutral insider sentiment. Scores between 40-60 represent neutral or mixed activity. With $13.6M in purchases and $9.1M in sales, no strong directional conviction is evident.

The most recent insider transaction occurred on Oct 30, 2025, when Ackerman Joel (Executive) disposed of 94,405 shares at $2.10 per share for $198.3K. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, CSBR insider trading sentiment is currently neutral with an Alignment Score of 60/100. The balanced activity—$13.6M bought vs $9.1M sold—suggests no strong consensus among insiders.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like CHAMPIONS BIOTECHNOLOGY, INC.. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At CSBR, we track all Form 4 filings—currently showing 184 transactions from 17 insiders over 90 days.

A 10b5-1 plan allows CHAMPIONS BIOTECHNOLOGY, INC. executives to pre-schedule stock sales when they don't possess material non-public information. At CSBR, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at CSBR appears discretionary, making insider signals more meaningful.

You can monitor CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 17 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. CHAMPIONS BIOTECHNOLOGY, INC.'s current score of 60/100 indicates moderately bullish sentiment suggesting insider confidence. This is calculated from $13.6M in purchases versus $9.1M in sales over 90 days, resulting in a net flow of $4.5M.

SEC Form 4 filings are mandatory reports that CHAMPIONS BIOTECHNOLOGY, INC. insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At CSBR, the most common type is "P" with 26 occurrences. The most recent Form 4 was filed on Oct 30, 2025 by Ackerman Joel.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At CHAMPIONS BIOTECHNOLOGY, INC., approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at CSBR represents discretionary decisions with more informational value.